Dedicated to the Safe, Clinically Effective and Globally Accessible CAR & TCR Based Cell Therapies in Oncology & Beyond
The 6th CAR-TCR Summit will return in 2021 as the industry-leading comprehensive forum with one goal: to engineer a disease-free world.
Bringing together CAR and TCR experts from pharma, biotech and academia, this unique platform will provide you with unrivaled networking opportunities with senior level drug developers as well as ground-breaking science and solution-led case studies. Delving into the pioneering developments from early discovery through to late-stage commercialization, this is 4 days your team cannot afford to miss!
Introducing the 2021 Scientific Advisory Board
Global Head Translational Medicine
Kite: A Gilead Company
SVP, R&D Governance Chair & Therapeutic Area Head Oncology
Barbara and Edward Netter Professor in Cancer Gene Therapy
Perelman School of Medicine
CEO & CSO
SVP, Global Cell Therapy Franchise Lead
Bristol Myers Squibb
“To support the CAR-TCR Summit in its role at the forefront of the industry, providing a progressive end-to-end forum, we have shared our expertise to shape the agenda into a truly ‘don’t miss’ event”
CAR-TCR Scientific Advisory Board